Beyond Air (XAIR) Competitors $2.70 +0.05 (+1.96%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XAIR vs. GUTS, LUNG, BDMD, PSTV, DXR, ICCM, QTI, TELA, CTSO, and MDAIShould you be buying Beyond Air stock or one of its competitors? The main competitors of Beyond Air include Fractyl Health (GUTS), Pulmonx (LUNG), Baird Medical Investment (BDMD), Plus Therapeutics (PSTV), Daxor (DXR), IceCure Medical (ICCM), QT Imaging (QTI), TELA Bio (TELA), Cytosorbents (CTSO), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry. Beyond Air vs. Its Competitors Fractyl Health Pulmonx Baird Medical Investment Plus Therapeutics Daxor IceCure Medical QT Imaging TELA Bio Cytosorbents Spectral AI Beyond Air (NASDAQ:XAIR) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk. Does the media prefer XAIR or GUTS? In the previous week, Fractyl Health had 11 more articles in the media than Beyond Air. MarketBeat recorded 11 mentions for Fractyl Health and 0 mentions for Beyond Air. Fractyl Health's average media sentiment score of 0.99 beat Beyond Air's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the news media. Company Overall Sentiment Beyond Air Neutral Fractyl Health Positive Which has more volatility & risk, XAIR or GUTS? Beyond Air has a beta of 0.29, meaning that its share price is 71% less volatile than the S&P 500. Comparatively, Fractyl Health has a beta of 2.27, meaning that its share price is 127% more volatile than the S&P 500. Do insiders & institutionals hold more shares of XAIR or GUTS? 31.5% of Beyond Air shares are owned by institutional investors. 19.4% of Beyond Air shares are owned by company insiders. Comparatively, 26.1% of Fractyl Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts prefer XAIR or GUTS? Beyond Air currently has a consensus target price of $11.00, suggesting a potential upside of 307.11%. Fractyl Health has a consensus target price of $6.90, suggesting a potential upside of 394.62%. Given Fractyl Health's higher probable upside, analysts clearly believe Fractyl Health is more favorable than Beyond Air.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67Fractyl Health 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has stronger earnings and valuation, XAIR or GUTS? Beyond Air has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeyond Air$3.70M5.79-$46.62M-$11.93-0.23Fractyl Health$90K779.50-$68.69M-$2.06-0.68 Is XAIR or GUTS more profitable? Fractyl Health has a net margin of 0.00% compared to Beyond Air's net margin of -880.72%. Beyond Air's return on equity of -232.61% beat Fractyl Health's return on equity.Company Net Margins Return on Equity Return on Assets Beyond Air-880.72% -232.61% -115.92% Fractyl Health N/A -584.35%-102.88% SummaryFractyl Health beats Beyond Air on 10 of the 17 factors compared between the two stocks. Get Beyond Air News Delivered to You Automatically Sign up to receive the latest news and ratings for XAIR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAIR vs. The Competition Export to ExcelMetricBeyond AirMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.41M$12.26B$9.05B$10.58BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-0.2321.6485.8427.32Price / Sales5.79275.72535.95201.92Price / CashN/A47.1237.9261.55Price / Book0.8110.4113.026.76Net Income-$46.62M-$52.40M$3.30B$275.79M7 Day Performance8.08%6.34%4.69%2.44%1 Month Performance6.38%16.09%9.86%8.86%1 Year Performance-62.21%33.38%84.90%35.45% Beyond Air Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAIRBeyond Air3.8678 of 5 stars$2.70+2.0%$11.00+307.1%-63.1%$21.41M$3.70M-0.2370Positive NewsGap DownGUTSFractyl Health3.519 of 5 stars$1.47-5.2%$6.90+369.4%-41.4%$77.95M$90K0.00102Analyst ForecastShort Interest ↓LUNGPulmonx3.2562 of 5 stars$1.74-5.4%$7.66+340.5%-73.0%$74.97M$83.79M0.00250News CoverageAnalyst ForecastBDMDBaird Medical InvestmentN/A$1.67-18.1%N/A-59.1%$72.89MN/A0.00N/ANews CoverageAnalyst ForecastHigh Trading VolumePSTVPlus Therapeutics3.8906 of 5 stars$0.89+21.6%$8.00+799.4%-44.7%$72.58M$5.82M0.0020Analyst ForecastGap UpDXRDaxor3.8252 of 5 stars$13.81-0.6%$25.00+81.0%+48.6%$67.23MN/A0.0037Analyst ForecastShort Interest ↓Gap DownICCMIceCure Medical3.1233 of 5 stars$1.00+3.7%$2.39+138.5%+67.4%$66.23M$3.29M0.0060Analyst ForecastAnalyst RevisionHigh Trading VolumeQTIQT ImagingN/A$2.33+0.1%N/A+269.7%$63.26M$4.00M0.00N/AGap DownTELATELA Bio1.9304 of 5 stars$1.52-2.9%$4.50+197.0%-38.8%$61.80M$69.30M0.00120News CoveragePositive NewsAnalyst ForecastCTSOCytosorbents1.3897 of 5 stars$0.94-4.5%$5.50+485.1%-13.7%$61.76M$35.60M0.00220Gap DownMDAISpectral AI2.4718 of 5 stars$2.42+8.5%$3.50+44.6%+134.3%$59.61M$29.58M0.0083News CoverageAnalyst ForecastGap UpHigh Trading Volume Related Companies and Tools Related Companies Fractyl Health Competitors Pulmonx Competitors Baird Medical Investment Competitors Plus Therapeutics Competitors Daxor Competitors IceCure Medical Competitors QT Imaging Competitors TELA Bio Competitors Cytosorbents Competitors Spectral AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XAIR) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beyond Air With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
